Medical Supervision and Microdosing Beverly Tchang, MD, an endocrinologist and obesity specialist at NewYork-Presbyterian and Weill Cornell Medicine in New York City, instructs some of her patients to microdose to help balance side effects with weight loss goals
Clinical Considerations and Future Outlook For the clinician, these emerging therapies signal a move toward highly personalised obesity medicine
This gatekeeping creates a two-tier system where only insured individuals in specific income brackets can afford treatment
It names fasting glucose, HbA1c, lipid profiles and inflammatory markers, evaluated roughly six to eight weeks after starting and again at each step
The theoretical risk of over-activating the GH-IGF-1 axis, including acromegalic side effects and proliferative signaling, is additive